Skip to content
National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Division of Cancer Prevention logo
Home Site Map Contact DCP
Programs & Resources

Breast and Gynecologic Cancer Research Group

Publications

View All  |  2014-2010  |  2009-2004

2014

  • Felix AS, Weissfeld JL, Pfeiffer RM, Modugno F, Black A, Hill LM, Martin J, Sit AS, Sherman ME, Brinton LA. Endometrial thickness and risk of breast and endometrial carcinomas in the Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial. Int J Cancer. 2014 Feb;134(4):954-60. Epub 2013 Aug 28.
    [ PubMed Abstract ]
  • Garcia FA, Cornelison T, Nuño T, Greenspan DL, Byron JW, Hsu CH, Alberts DS, Chow HH. Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia. Gynecol Oncol. 2014 Jan 2. [Epub ahead of print]
    [ PubMed Abstract ]
  • Horne HN, Sherman ME, Garcia-Closas M, Pharoah PD, Blows FM, Yang XR, Hewitt SM, Conway CM, Lissowska J, Brinton LA, Prokunina-Olsson L, Dawson SJ, Caldas C, Easton DF, Chanock SJ, Figueroa JD. Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression. Breast Cancer Res Treat. 2014 Jan;143(1):181-7. Epub 2013 Nov 30.
    [ PubMed Abstract ]

2013

  • Brinton LA, Felix AS, McMeekin DS, Creasman WT, Sherman ME, Mutch D, Cohn DE, Walker JL, Moore RG, Downs LS, Soslow RA, Zaino R. Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial. Gynecol Oncol. 2013 May;129(2):277-84. Epub 2013 Feb 26.
    [ PubMed Abstract ]
  • Chawla N, Kepka DL, Heckman-Stoddard BM, Horne HN, Felix AS, Luhn P, Pelser C, Barkley J, Faupel-Badger JM. Health disparities around the world: perspectives from the 2012 principles and practice of cancer prevention and control course at the national cancer institute. J Oncol Pract. 2013 Nov 1;9(6):e284-9. Epub 2013 Oct 1.
    [ PubMed Abstract ]
  • Faupel-Badger JM, Arcaro KF, Balkam JJ, Eliassen AH, Hassiotou F, Lebrilla CB, Michels KB, Palmer JR, Schedin P, Stuebe AM, Watson CJ, Sherman ME. Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop. J Natl Cancer Inst. 2013 Feb 6;105(3):166-74. Epub 2012 Dec 21. Review.
    [ PubMed Abstract ]
  • Faupel-Badger JM, Duggan MA, Sherman ME, Garcia-Closas M, Yang XR, Lissowska J, Brinton LA, Peplonska B, Vonderhaar BK, Figueroa JD. Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland. Horm Cancer. 2013 Nov 19. [Epub ahead of print]
    [ PubMed Abstract ]
  • Gage JC, Schiffman M, Solomon D, Wheeler CM, Gravitt PE, Castle PE, Wentzensen N. Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities. Cancer Epidemiol Biomarkers Prev. 2013 Jun;22(6):1095-101. Epub 2013 Apr 19.
    [ PubMed Abstract ]
  • Gierach GL, Pfeiffer RM, Patel DA, Black A, Schairer C, Gill A, Brinton LA, Sherman ME. Long-term overall and disease-specific mortality associated with benign gynecologic surgery performed at different ages. Menopause. 2013 Nov 18. [Epub ahead of print]
    [ PubMed Abstract ]
  • Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, Jimenez S, Schiller JT, Lowy DR, van Doorn LJ, Wacholder S, Kreimer AR; CVT Vaccine Group. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One. 2013 Jul 17;8(7):e68329.
    [ PubMed Abstract ]
  • Keller MJ, Buckley N, Katzen LL, Walsh J, Friedland B, Littlefield S, Lin J, Xue X, Cornelison T, Herold BC, Einstein MH. Use of the dye stain assay and ultraviolet light test for assessing vaginal insertion of placebo-filled applicators before and after sex. Sex Transm Dis. 2013 Dec;40(12):939-43.
    [ PubMed Abstract ]
  • Koshiol J, Dunn ST, Walker JL, Zuna RE, Schiffman M, Sherman ME, Gold MA, Allen RA, Zhang R, Wang SS, Wentzensen N. Reproducibility of linear array for human papillomavirus genotyping. J Clin Microbiol. 2013 Feb;51(2):625-8. Epub 2012 Nov 28.
    [ PubMed Abstract ]
  • Lang Kuhs KA, Gonzalez P, Struijk L, Castro F, Hildesheim A, van Doorn LJ, Rodriguez AC, Schiffman M, Quint W, Lowy DR, Porras C, Delvecchio C, Katki HA, Jimenez S, Safaeian M, Schiller J, Solomon D, Wacholder S, Herrero R, Kreimer AR; Costa Rica Vaccine Trial Group. Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica. J Infect Dis. 2013 Nov 15;208(10):1643-52. Epub 2013 Sep 6.
    [ PubMed Abstract ]
  • Lu KH, Loose DS, Yates MS, Nogueras-Gonzalez GM, Munsell MF, Chen LM, Lynch H, Cornelison T, Boyd-Rogers S, Rubin M, Daniels MS, Conrad P, Milbourne A, Gershenson DM, Broaddus RR. Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome. Cancer Prev Res (Phila). 2013 Aug;6(8):774-81. Epub 2013 May 2.
    [ PubMed Abstract ]
  • Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, Solomon D, Wentzensen N, Lawson HW; 2012 ASCCP Consensus Guidelines Conference. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol. 2013 Apr;121(4):829-46.
    [ PubMed Abstract ]
  • Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, Solomon D, Wentzensen N, Lawson HW; 2012 ASCCP Consensus Guidelines Conference. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S1-S27. Erratum in: J Low Genit Tract Dis. 2013 Jul;17(3):367.
    [ PubMed Abstract ]
  • Matsuno RK, Sherman ME, Visvanathan K, Goodman MT, Hernandez BY, Lynch CF, Ioffe OB, Horio D, Platz C, Altekruse SF, Pfeiffer RM, Anderson WF. Agreement for tumor grade of ovarian carcinoma: analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repository. Cancer Causes Control. 2013 Apr;24(4):749-57. Epub 2013 Feb 3.
    [ PubMed Abstract ]
  • Murphy RA, Schairer C, Gierach GL, Byrne C, Sherman ME, Register TC, Ding J, Kritchevsky SB, Harris TB. Beyond breast cancer: mammographic features and mortality risk in a population of healthy women. PLoS One. 2013 Oct 25;8(10):e78722.
    [ PubMed Abstract ]
  • Musuuza JS, Sherman ME, Knudsen KJ, Sweeney HA, Tyler CV, Koroukian SM. Analyzing excess mortality from cancer among individuals with mental illness. Cancer. 2013 Jul 1;119(13):2469-76. Epub 2013 Apr 12.
    [ PubMed Abstract ]
  • Rodríguez AC, Solomon D, Herrero R, Hildesheim A, González P, Wacholder S, Porras C, Jiménez S, Schiffman M; CVT Group. Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatment. Am J Epidemiol. 2013 Sep 1;178(5):752-60. Epub 2013 Jul 10.
    [ PubMed Abstract ]
  • Safaeian M, Sherman ME. From Papanicolaou to papillomaviruses: evolving challenges in cervical cancer screening in the era of human papillomavirus vaccination. J Natl Cancer Inst. 2013 Oct 16;105(20):1524-6. Epub 2013 Oct 4.
    [ PubMed Abstract ]
  • Sieh W, Köbel M, Longacre TA, Bowtell DD, deFazio A, Goodman MT, Høgdall E, Deen S, Wentzensen N, Moysich KB, Brenton JD, Clarke BA, Menon U, Gilks CB, Kim A, Madore J, Fereday S, George J, Galletta L, Lurie G, Wilkens LR, Carney ME, Thompson PJ, Matsuno RK, Kjær SK, Jensen A, Høgdall C, Kalli KR, Fridley BL, Keeney GL, Vierkant RA, Cunningham JM, Brinton LA, Yang HP, Sherman ME, et al. Hormone-receptor expression and ovarian cancer survival: an ovarian tumor tissue analysis consortium study. Lancet Oncol. 2013 Aug;14(9):853-62.Epub 2013 Jul 9.
    [ PubMed Abstract ]
  • Sherman ME, Mies C, Gierach GL. Opportunities for molecular epidemiological research on ductal carcinoma in-situ and breast carcinogenesis: interdisciplinary approaches. Breast Dis. 2013 Nov 13. Epub ahead of print.
    [ PubMed Abstract ]
  • Sun X, Gierach GL, Sandhu R, Williams T, Midkiff BR, Lissowska J, Wesolowska E, Boyd NF, Johnson NB, Figueroa JD, Sherman ME, Troester MA. Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer. Clin Cancer Res. 2013 Sep 15;19(18):4972-82. Epub 2013 Aug 5.
    [ PubMed Abstract ]
  • Trabert B, Wentzensen N, Yang HP, Sherman ME, Hollenbeck AR, Park Y, Brinton LA. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk? Int J Cancer. 2013 Jan 15;132(2):417-26. Epub 2012 Aug 30.
    [ PubMed Abstract ]
  • Visvanathan K, Hurley P, Bantug E, Brown P, Col NF, Cuzick J, Davidson NE, Decensi A, Fabian C, Ford L, Garber J, Katapodi M, Kramer B, Morrow M, Parker B, Runowicz C, Vogel VG 3rd, Wade JL, Lippman SM. Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013 Aug 10;31(23):2942-62. Epub 2013 Jul 8. Review. Erratum in: J Clin Oncol. 2013 Dec 1;31(34):4383.
    [ PubMed Abstract ]
  • Wartko P, Sherman ME, Yang HP, Felix AS, Brinton LA, Trabert B. Recent changes in endometrial cancer trends among menopausal-age U.S. women. Cancer Epidemiol. 2013 Aug;37(4):374-7. Epub 2013 Apr 13.
    [ PubMed Abstract ]
  • Yang HP, Anderson WF, Rosenberg PS, Trabert B, Gierach GL, Wentzensen N, Cronin KA, Sherman ME. Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States. J Clin Oncol. 2013 Jun 10;31(17):2146-51. Epub 2013 May 6.
    [ PubMed Abstract ]
  • Yang XR, Figueroa JD, Hewitt SM, Falk RT, Pfeiffer RM, Lissowska J, Peplonska B, Brinton LA, Garcia-Closas M, Sherman ME. Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer. Breast Cancer Res Treat. 2013 Feb;137(3):837-47. Epub 2012 Dec 28.
    [ PubMed Abstract ]
  • Yang HP, Wentzensen N, Trabert B, Gierach GL, Felix AS, Gunter MJ, Hollenbeck A, Park Y, Sherman ME, Brinton LA. Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP Diet and Health Study. Am J Epidemiol. 2013 Jan 15;177(2):142-51. Epub 2012 Nov 21.
    [ PubMed Abstract ]

2012

  • Crew KD, Brown P, Greenlee H, Bevers TB, Arun B, Hudis C, McArthur HL, Chang J, Rimawi M, Vornik L, Cornelison TL, Wang A, Hibshoosh H, Ahmed A, Terry MB, Santella RM, Lippman SM, Hershman DL. Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer. Cancer Prev Res (Phila). 2012 Sep;5(9):1144-54. Epub 2012 Jul 24.
    [ PubMed Abstract ]
  • Forsythe LP, Gadalla SM, Hamilton JG, Heckman-Stoddard BM, Kent EE, Lai GY, Lin SW, Luhn P, Faupel-Badger JM. Enhancing a cancer prevention and control curriculum through interactive group discussions. J Cancer Educ. 2012 Jun;27(3):428-35.
    [ PubMed Abstract ]
  • Heckman-Stoddard BM. Oncology biomarkers: discovery, validation, and clinical use. Semin Oncol Nurs. 2012 May;28(2):93-8. Review.
    [ PubMed Abstract ]
  • Lazzeroni M, Serrano D, Dunn BK, Heckman-Stoddard BM, Lee O, Khan S, Decensi A. Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug. Breast Cancer Res. 2012 Oct 29;14(5):214. [Epub ahead of print]
    [ PubMed Abstract ]
  • Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS Jr, Spitzer M, Moscicki AB, Franco EL, Stoler MH, Schiffman M, Castle PE, Myers ER; American Cancer Society; American Society for Colposcopy and Cervical Pathology; American Society for Clinical Pathology. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012 Apr;137(4):516-42.
    [ PubMed Abstract ]
  • Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS Jr, Spitzer M, Moscicki AB, Franco EL, Stoler MH, Schiffman M, Castle PE, Myers ER; ACS-ASCCP-ASCP Cervical Cancer Guideline Committee. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012 May-Jun;62(3):147-72. Epub 2012 Mar 14.
    [ PubMed Abstract ]
  • Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS Jr, Spitzer M, Moscicki AB, Franco EL, Stoler MH, Schiffman M, Castle PE, Myers ER, Chelmow D, Herzig A, Kim JJ, Kinney W, Herschel WL, Waldman J. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis. 2012 Jul;16(3):175-204. Review.
    [ PubMed Abstract ]

2011

  • Herrero R, Wacholder S, Rodríguez AC, Solomon D, González P, Kreimer AR, Porras C, Schussler J, Jiménez S, Sherman ME, Quint W, Schiller JT, Lowy DR, Schiffman M, Hildesheim A; Costa Rica Vaccine Trial Group. Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica. Cancer Discov. 2011 Oct;1(5):408-19. Epub 2011 Sep 9.
    [ PubMed Abstract ]
  • Kreimer AR, González P, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, Jiménez S, Schiller JT, Lowy DR, van Doorn LJ, Struijk L, Quint W, Chen S, Wacholder S, Hildesheim A, Herrero R; CVT Vaccine Group. Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial. Lancet Oncol. 2011 Sep;12(9):862-70. doi: 10.1016/S1470-2045(11)70213-3. Epub 2011 Aug 22. Erratum in: Lancet Oncol. 2011 Nov;12(12):1096.
    [ PubMed Abstract ]
  • Kreimer AR, Rodriguez AC, Hildesheim A, Herrero R, Porras C, Schiffman M, González P, Solomon D, Jiménez S, Schiller JT, Lowy DR, Quint W, Sherman ME, Schussler J, Wacholder S; CVT Vaccine Group. Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine. J Natl Cancer Inst. 2011 Oct 5;103(19):1444-51. Epub 2011 Sep 9.
    [ PubMed Abstract ]
  • Lubet RA, Heckman BM, De Flora SL, Steele VE, Crowell JA, Juliana MM, Grubbs CJ. Effects of 5,6-benzoflavone, indole-3-carbinol (I3C) and diindolylmethane (DIM) on chemically-induced mammary carcinogenesis: is DIM a substitute for I3C? Oncol Rep. 2011 Sep;26(3):731-6. Epub 2011 May 23.
    [ PubMed Abstract ]
  • Porras C, Wentzensen N, Rodríguez AC, Morales J, Burk RD, Alfaro M, Hutchinson M, Herrero R, Hildesheim A, Sherman ME, Wacholder S, Solomon D, Schiffman M. Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy. Int J Cancer. 2012 Apr 15;130(8):1879-87. Epub 2011 Aug 2.
    [ PubMed Abstract ]

2010

  • Agurs-Collins T, Dunn BK, Browne D, Johnson KA, Lubet R. Epidemiology of health disparities in relation to the biology of estrogen receptor-negative breast cancer. Semin Oncol. 2010 Aug;37(4):384-401.
    [ PubMed Abstract ]
  • Eng-Wong J, Venzon D, Cohen P, Isaacs C, Warren R, Wedam S, Zujewski JA, Korde L. Effect of exemestane on mammographic density in postmenopausal women at risk for breast cancer. San Antonio Breast Cancer Symposium 2010 Abstract P1-07-03.
  • Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Petroff BK, Khan QJ, Sharma P, Setchell KD, Zhao X, Phillips TA, Metheny T, Hughes JR, Yeh HW, Johnson KA. Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside. Cancer Prev Res. 2010 Oct;3(10):1342-1350.
    [ PubMed Abstract ]
  • Huang L, Johnson KA, Mariotto AB, Dignam JJ, Feuer EJ. Population-based survival-cure analysis of ER-negative breast cancer. Breast Cancer Res Treat. 2010 Aug;123(1):257-264.
    [ PubMed Abstract ]
  • Johnson KA, Brown PH. Drug development for cancer chemoprevention: focus on molecular targets. Seminars in Oncology, 2010. 37(4):345-358.
    [ PubMed Abstract ]
  • McHenry PR, Sears JC, Herrick MP, Chang P, Heckman-Stoddard BM, Rybarczyk M, Chodosh LA, Gunther EJ, Hilsenbeck SG, Rosen JM, Vargo-Gogola T. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis. Breast Cancer Res. 2010 Sep 22;12(5):R73.
    [ PubMed Abstract ]
  • Porras C, Bennett C, Safaeian M, Coseo S, Rodríguez AC, González P, Hutchinson M, Jiménez S, Sherman ME, Wacholder S, Solomon D, van Doorn LJ, Bougelet C, Quint W, Schiffman M, Herrero R, Hildesheim A; Costa Rica HPV Vaccine Trial (CVT) Group. Determinants of seropositivity among HPV-16/18 DNA positive young women. BMC Infect Dis. 2010 Aug 11;10:238.
    [ PubMed Abstract ]
  • Zou C, Liu H, Feugang JM, Hao Z, Chow HH, Garcia F. Green tea compound in chemoprevention of cervical cancer. Int J Gynecol Cancer. 2010 May;20(4):617-24.
    [ PubMed Abstract ]

2009

  • Chun J, Schnahel F, Ogunyemi O. Assessment of breast cancer risk prediction models in a high-risk population. Cancer Res. 2009 Feb 19;69(2)Supplement 1; SABCS-4074.
  • Decensi A, Robertson C, Guerrieri-Gonzaga A, Serrano D, Cazzaniga M, Mora S, Gulisano M, Johansson H, Galimberti V, Cassano E, Moroni SM, Formelli F, Lien EA, Pelosi G, Johnson KA, Bonanni B. Randomized Double-Blind 2 X 2 Trial of Low-Dose Tamoxifen and Fenretinide for Breast Cancer Prevention in High-Risk Premenopausal Women. J Clin Oncol. 2009 Aug 10;27(23):3749-56.
    [ PubMed Abstract ]
  • Eng-Wong J, Reynolds JC, Venzon D, Wedam S, Prindiville S, Zujewski JA, Korde L. Effect of exemestane on bone mineral density in postmenopausal women at increased risk for breast cancer. Cancer Res. 2009 Feb19 69(2)Supplement 2; SABCS-5086.
  • Fabian CJ, Khan QJ, Sharma P, Baxa S, Metheny T, Zalles CM, Kimler BF. Evaluation of Ki-67 measured in benign breast tissue acquired from premenopausal women treated with a flaxseed derivative. J Clin Oncol. 2009 27(15):1507.
  • Heckman-Stoddard BM, Vargo-Gogola T, McHenry PR, Jiang V, Herrick MP, Hilsenbeck SG, Settleman J, Rosen JM. Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression. Breast Cancer Res. 2009;11(4):R61.
    [ PubMed Abstract ]
  • Trimble CL, Peng S, Kos F, Gravitt P, Viscidi R, Sugar E, Pardoll D, Wu TC. A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3. Clin Cancer Res. 2009 Jan 1;15(1):361-7.
    [ PubMed Abstract ]

2008

  • Galgano MT, Castle PE, Stoler MH, Solomon D, Schiffman M. Can HPV-16 Genotyping Provide a Benchmark for Cervical Biopsy Specimen Interpretation? Am J Clin Pathol. 2008 Jul;130(1):65-70.
    [ PubMed Abstract ]
  • Herrero R, Hildesheim A, Rodríguez AC, Wacholder S, Bratti C, Solomon D, González P, Porras C, Jiménez S, Guillen D, Morales J, Alfaro M, Cyr J, Morrisey K, Estrada Y, Cortés B, Morera LA, Freer E, Schussler J, Schiller J, Lowy D, Schiffman M ; Costa Rica Vaccine Trial (CVT) Group. Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica. Vaccine. 2008 Sep 2;26(37):4795-808.
    [ PubMed Abstract ]
  • Lin MC, Lomo L, Baak JP, Eng C, Ince TA, Crum CP, Mutter GL. Squamous morules are functionally inert elements of premalignant endometrial neoplasia. Mod Pathol. 2009 Feb;22(2):167-74.
    [ PubMed Abstract ]
  • Mutter GL, Kauderer J, Baak JP, Alberts D ; Gynecologic Oncology Group. Biopsy histomorphometry predicts uterine myoinvasion by endometrial carcinoma: a Gynecologic Oncology Group study. Hum Pathol. 2008 Jun;39(6):866-74.
    [ PubMed Abstract ]
  • Nayar R, Solomon D. Support from authors of the Bethesda system. Cytopathology., 2008 Jun;19(3):137-57.
    [ PubMed Abstract ]
  • Windram OP, Weber B, Jaffer MA, Rybicki EP, Shepherd DN, Varsani A. An investigation into the use of human papillomavirus type 16 virus-like particles as a delivery vector system for foreign proteins: N- and C-terminal fusion of GFP to the L1 and L2 capsid proteins. Arch Virol. 2008 153(3):585-9.
    [ PubMed Abstract ]

2007

  • Arun B, Valero V, Logan C, Broglio K, Rivera E, Brewster A, Yin G, Green M, Kuerer H, Gong Y, Browne D, Hortobagyi GN, Sneige N. Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials. Clin Cancer Res. 2007 13(16):4943-4948.
    [ PubMed Abstract ]
  • Brown P, Arun B, Miller A, Isaacs C, Gutierrez C, Huang J, Mohsin S, Sneige N, Kim H, Sexton K, Weiss H, Hilsenbeck S, Lamph W, Negro-Vilar A, Johnson K, Elledge R. Prevention of breast cancer using rexinoids: results of a phase II biomarker modulation trial using bexarotene in women at high risk of breast cancer. Breast Cancer Res Treat. 2007 106:S181-S182.
  • Carreon J, Sherman ME, Guillen D, Solomon D, Herrero R et al. CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples. Int J Gynecol Pathol. 2007 Oct;26:441-6.
    [ PubMed Abstract ]
  • Castle P, Sideri M, Jeronimo J, Solomon D, Schiffman M. Risk assessment to guide the prevention of cervical cancer. Am J Obstet Gynecol. 2007 Oct;197(4):356.e1-6.
    [ PubMed Abstract ]
  • Fabian CJ, Kimler BF, Mayo MS, Zalles CH, Khan SA, Dooley WC, Krontiras H, Browne D. Phase II tissue-based biomarker prevention trial of celecoxib in premenopausal women at high risk for development of breast cancer. Breast Cancer Res Treat. 2007 106:S179-S179.
  • Hildesheim A, Herrero R, Wacholder S, Rodrigues AC, Solomon D, et al. Effect of Human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection. JAMA. 2007 Aug 15;298(7):743-53.
    [ PubMed Abstract ]
  • Kelloff GJ, Sullivan DC, Baker H, et al. Workshop on imaging science development for cancer prevention and preemption. Cancer Biomark. 2007 3(1):1-33.
  • Lord SJ, Bernstein L, Johnson K, Malone K, Weiss L, McDonald J, Ursin G. Parity, breastfeeding and breast cancer risk by hormone receptor status in women with late age at first birth - a case-control study. Proc. American Association for Cancer Research. 2007 48:622(Abstract #2610).
  • Macis D, Gandini S, Johansson A. COMT V158M, mammographic density and circulating sex hormones in a randomized, double-blind 2 x 2 phase II trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women. Frontiers in Cancer Prevention Research, Programs and Proceedings. 2007 Abstract B105;152.
  • Safaeian M, Solomon D. Cervical cancer prevention–cervical screening: science in evolution. In: Obstetrics and Gynecology Clinics of North America. Philadelphia, PA: Saunders; 2007.
    [ PubMed Abstract ]
  • Safaeian M, Solomon D, Wacholder S, Schiffman M, Castle P. Risk of precancer and follow-up management strategies for women with HPV-negative atypical squamous cells of undetermined significance. Obstet Gynecol. 2007 Jun;109(6):1325-31.
    [ PubMed Abstract ]
  • Sherman ME, das Gupta A, Schiffman M, Nayar R, Solomon D. Bethesda Interobserver Reproducibility Study (BIRST). Cancer Cytopathol. 2007;111:15-25.
  • Solomon D, Breen N, McNeel T. Cervical cancer screening rates and potential impact of implementation of screening guidelines. CA Cancer J Clin. 2007 57:105-11.
  • Solomon D, Stoler M, Jeronimo J, Khan M, Castle P, Schiffman M. Diagnostic utility of endocervical curettage in women undergoing colposcopy for equivocal or low grade cytologic abnormalities. Obstet Gynecol. 2007 Aug;110(2 Pt 1):288-95.
    [ PubMed Abstract ]
  • Stoler MH, Castle PE, Solomon D, Schiffman M. The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays. Am J Clin Pathol. 2007 127:335-7.
  • Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D; 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol. 2007 Oct;197(4):340-5.
    [ PubMed Abstract ]
  • Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D; 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007 Oct;197:346-55.
    [ PubMed Abstract ]

2006

  • Arun B, Valero V, Yin G, Babiera G, Murray JL, Browne D, Gong Y, Cook E, Hortobagyi GN, Sneige N. Phase II breast cancer chemoprevention study with celecoxib in women at increased risk for breast cancer. J Clinl Oncol. 2006 24(18):51S-51S.
  • Chamberlain CS, Schmetze KH, Anderson JR, Khan SA, Dooley WC, Krontiras H, Browne D, Kimler BF, Fabian CJ. High risk women report minimal pain rating score with random periareolar fine needle aspirations compared to ductal lavage. 29th SABCS 2006.
  • Chatterton RT Jr, Zujewski J, Mateo ET, Eng-Wong J, Jordan VC. Effect of raloxifene on salivary sex steroid concentrations in premenopausal women. J Endocrinol. 2006 Dec;191(3):599-604.
    [ PubMed Abstract ]
  • Fabian CJ, Kimler, Anderson JR, Chamberlain C, Mayo MS, Khan SA, Dooley WC, Krontiras N, Browne D. Comparison of efficacy of random periareolar fine needle aspiration vs. ductal lavage for acquisition of breast tissue in meeting eligibility requirements for phase II chemoprevention study. 29 th SABCS, 2006.
  • Fabian CJ, Kimler BF, Anderson JR, Chamberlain C, Mayo MS, Zalles CM, O'Shaughnessy JA, Lynch HT, Johnson KA, Browne D. Phase II breast cancer chemoprevention trial of the third generation selective estrogen receptor modulator arzoxifene. J Clin Oncol. 2006 24(Suppl 18S)abstract 1001.
  • Foster K. Gynecologic cancers: ovarian and cervical cancer prevention. SoCRA Source: Society of Clinical Research Associates. Issue 48, May 2006.
  • Gage JC, Hanson VW, Abbey K, Dippery S, Gardner S, Kubota J, Schiffman M, Solomon D, Jeronimo J; ASCUS LSIL Triage Study (ALTS) Group. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol. 2006 Aug;108(2):264-72.
    [ PubMed Abstract ]
  • Guerrieri-Gonzaga A, Robertson C, Bonanni B, Serrano C, Cazzaniga M, Mora S, Gulisano M, Johansson H, Intra M, Latronico A, Franchi D, Pelosi G, Johnson K, Decensi A. preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women. J Clin Oncol. 2006 24:129-35.
  • Johnson KA. The SERM of My Dreams. J Clin Endocrinol Metab. 2006 91:3754-56.
  • Kim H-T, Duong S, Li Y, Uray I, DeNardo D, Hilsenbeck S, Tsimeizon A, Brown P, Bissonnette R, Lamph W, Johnson K. Discovery of rexinoid-modulated biomarkers in human breast cells using microarrays. Proc. American Association for Cancer Research. 2006 47:917(Abstract #3901).
  • Kimler BF, Fabian CJ, Methany T, Xue Q, Zalles CM, Mayo MS, Khan SA, Dooley WC, Krontiras N, Browne D. Comparison of cytomorphology and immunocytochemistry in breast epithelial cells obtained by random periareolar fine needle aspiration vs ductal lavage. 97th Annual AACR Meeting; 2006 (abstract 1425) p.336.
  • Kimler BF, Ursin G, Fabian CJ, Anderson JR, Chamberlain C, Mayo MS, O'Shaughnessy JA, Lynch HT, Johnson KA, Browne D. Effect of the third generation selective estrogen receptor modulator arzoxifene on mammographic breast density. J Clin Oncol. 2006 24(Suppl 18S):18s(abstract 562).
  • Kreimer AR, Guido R, Solomon D, Schiffman M, Wacholder S, Jeronimo J, Wheeler C, Castle P; the ASCUS-LSIL Triage Study (ALTS) Group. HPV testing following loop electrosurgical excision procedure (LEEP) identifies women at risk for post-treatment cervical intraepithelial neoplasia grade 2 or 3 disease. Cancer Epidemiol Biomarkers Prev. 2006 15(5):908-14.
    [ PubMed Abstract ]
  • Kulasingam SL, Kim JJ, Lawrence WF, Mandelblatt JS, Myers ER, Schiffman M, Solomon D, Goldie SJ; the ALTS Group. Cost effectiveness analysis based on the ASCUS and LSIL Triage Study. J Natl Cancer Inst. 2006 98:92-100.
  • Li Y, Hill J, Zhang Y, Kim H-T, Uray I, Bissonnette R, Lamph W, Johnson K, Brown P. Rexinoids prevent the development of premalignant mammary lesions in MMTV-erbB2 mice. Proc. American Association for Cancer Research. 2006 47:917(Abstract #3899).
  • Mariotto AB, Wesley MN, Cronin KA, Johnson KA, Feuer EJ. Estimates of long-term survival for newly diagnosed cancer patients. Cancer. 2006 106:2039-50.
  • Muss HB, Hunter CP, Johnson KA, editors. Treatment and management of cancer in the elderly. In: Basic and clinical oncology series. New York: Taylor and Francis Group; 2006.
  • Ørbo A, Rise CE, Mutter GL. Regression of latent endometrial precancers by progestin infiltrated intrauterine device. Cancer Res. 2006 Jun 1;66(11):5613-7.
    [ PubMed Abstract ]
  • Percival SS, Johnson KA, Milner JA. Opportunities and challenges for appropriate nutrition of the elderly cancer patient. In: Muss HB, Hunter CP, Johnson KA, editors. Treatment and management of cancer in the elderly. New York: Taylor and Francis Group; 2006. P.451-70.
  • Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF, Johnson KA, Johnson C, Buys SS, Hoover RN, Ziegler RG. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr. 2006 Apr;83(4):895-904.
  • Walker JL, Wang SS, Schiffman M, Solomon D; ASCUS LSIL Triage Study Group. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS/LSIL Triage Study. Letter to the Editor. Am J Obstet Gynecol. 2006 Aug;195(2):341-8.
    [ PubMed Abstract ]
  • Zuna RE, Wang SS, Schiffman M, Solomon D. Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesion. Cancer. 2006 Oct 25;108(5):288-97.

2005

  • Baak JP, Mutter GL, Robboy S, van Diest PJ, Uyterlinde AM, Orbo A, Palazzo J, Fiane B, Løvslett K, Burger C, Voorhorst F, Verheijen RH. The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer. 2005 Jun 1;103(11):2304-12.
    [ PubMed Abstract ]
  • Fabian CJ, Kimler BF, Anderson JR, Chamberlain CS, Mayo MS, Khan SA, Dooley WC, Krontiras H, Browne D. Comparison of random periareolar fine needle aspiration vs. ductal lavage for acquisition of breast tissue in meeting eligibility requirements for a phase II chemoprevention study. Fourth Annual AACR International Conference on Frontiers in Cancer Prevention Research. 2005 (abstract A56), p.83.

2004

  • Fabian CJ, Kimler BF, Anderson J, Tawfik OW, Mayo MS. Breast cancer chemoprevention Phase IB evaluation of biomarker modulation by arzoxifene, a third generation selective estrogen receptor modulator. J Clin Oncol. 2004 22(14_suppl): 1015.
  • Fabian CJ, Kimler BF, Anderson J, Tawfik OW, Mayo MS, Burak WE Jr, O'Shaughnessy JA, Albain KS, Hyams DM, Budd GT, Ganz PA, Sauter ER, Beenken SW, Grizzle WE, Fruehauf JP, Arneson DW, Bacus JW, Lagios MD, Johnson KA, Browne D. Breast cancer chemoprevention phase I evaluation of biomarker modulation by arzoxifene, a third generation selective estrogen receptor modulator. Clin Cancer Res. 2004 Aug 15;10(16):5403-17.
    [ PubMed Abstract ]
  • Hecht JL, Ince TA, Baak JP, Baker HE, Ogden MW, Mutter GL. Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis. Mod Pathol. 2005 Mar;18(3):324-30.
    [ PubMed Abstract ]
  • Zheng W, Baker HE, Mutter GL. Involution of PTEN-null endometrial glands with progestin therapy. Gynecol Oncol. 2004 Mar;92(3):1008-13.
    [ PubMed Abstract ]

Back to top